Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | KB2YT | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | LA |
weakness left arm; Premature ventricular contractions; Hives; Injection site redness; Injection site pain; Injection site swelling; This non-serious case was reported by a consumer via patient support programs and described the occurrence of injection site erythema in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 06-JAN-2025, the patient received the 1st dose of Shingrix (left deltoid) .5 ml. On 06-JAN-2025, less than a day after receiving Shingrix, the patient experienced injection site erythema (Verbatim: Injection site redness), injection site pain (Verbatim: Injection site pain) and injection site swelling (Verbatim: Injection site swelling). On 07-JAN-2025, the patient experienced hives (Verbatim: Hives). On 08-JAN-2025, the patient experienced premature ventricular contractions (Verbatim: Premature ventricular contractions). On 09-JAN-2025, the patient experienced weakness of arms (Verbatim: weakness left arm). On 13-JAN-2025, the outcome of the injection site erythema and injection site swelling were resolved (duration 7 days). The outcome of the injection site pain, hives and weakness of arms were resolving and the outcome of the premature ventricular contractions was unknown. It was unknown if the reporter considered the injection site erythema, injection site pain, injection site swelling, hives, weakness of arms and premature ventricular contractions to be related to Shingrix. It was unknown if the company considered the injection site erythema, injection site pain, injection site swelling, hives, weakness of arms and premature ventricular contractions to be related to Shingrix. Additional Information: GSK Receipt Date: 18-FEB-2025 1 day after vaccination, the patient had experienced hives. 2 days after vaccination, the patient had weakness of left arm. 3 days after vaccination, the patient had premature ventricular contractions. Topical antihistamine was used.